Although involvement of FGF signalling has been reported in inflammatory diseases and in the tumour microenvironment 44, the mechanisms that underlie early suppression of the inflammatory response by S249C‐mutated FGFR3 are currently unknown. This evidence concerns the gene FGFR3 and neoplasm.